Cardiol Therapeutics Inc. (TSX:CRDL)
1.400
-0.020 (-1.41%)
At close: Dec 22, 2025
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 138.4 million as of December 23, 2025. Its market cap has decreased by -18.46% in one year.
Market Cap
138.40M
Enterprise Value
126.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 138.40M, an increase of 46.74%. That is a compound annual growth rate of 5.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 138.40M | -8.33% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | 91.34M | -22.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.20B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.08B |
| Sienna Senior Living | 2.00B |
| Trulieve Cannabis | 1.76B |
| Cronos Group | 1.47B |
| WELL Health Technologies | 995.62M |